Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Kedudukan dalam Saham #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Harga Saham
$0.25974701
Disegerakkan terakhir: 2025-01-06
Modal Pasaran
$2.04M
Perubahan (1 hari)
0.74%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Acticor Biotech SAS (ALACT)

Kategori

Sejarah harga saham bagi Acticor Biotech SAS (ALACT)
Harga penutupan tertinggi: $0.26 pada 2025-01-01

Harga penutupan terendah: $7.56 pada 2021-11-01
Sejarah harga saham Acticor Biotech SAS dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2025 -4.45%
2024 -91.43%
2023 -58.60%
2022 31.92%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$515.26 31.04%
US
$987.98 30.54%
NL
$122.35 -10.30%
AU
$142.87 498.26%
US
$697.62 1.32%
CH